Page 1700 - Clinical Small Animal Internal Medicine

1638 Index

tetracyclines postoperative spotted fever and typhus group
VetBooks.ir salmon poisoning disease 914 pulse oximetry and end‐tidal TIMP see tissue inhibitors of matrix
hemotropic Mycoplasma 929
monitoring 327–328
Rickettsia 937–940
metalloproteinases
CO 2 327
side‐effects and drug–drug
interactions 1047–1048 thoracotomy tubes and pleural TIO see tumor‐induced osteomalacia
tetralogy of Fallot (ToF) 234, 243 drainage 327, 328, 330, tissue Doppler imaging
3
tFAST see trauma, triage, and 335, 343 (TDI) 152, 161
tracking THR see total hip replacement tissue inhibitors of matrix
TFAST see thoracic focused three‐dimensional metalloproteinases
assessment with sonography echocardiography 152 (TIMP) 182, 245
for trauma thrombocytopenia tissue plasminogen activator (t‐PA)
Th see helper T lymphocytes cirrhosis 706 320–321
therapeutic plan 1396 ehrlichiosis and anaplasmosis TKI see tyrosine kinase inhibitors
therapeutic plasma exchange (TPE) 903–905, 911 TLI see trypsin‐like immunoreactivity
1179–1180, 1370–1371 essential thrombocytopenia TLR see toll‐like receptors
thermoregulation 1228–1229 TMT see transient myocardial
fever 434–435 paraneoplastic syndromes thickening
heat stroke 435–436 1219–1220 TNM see tumor‐node‐metastasis
normal thermoregulation 431 plasma cell disorders 1241 tobacco smoking 7
see also hyperthermia; hypothermia pulmonary thromboembolism 317 ToF see tetralogy of Fallot
thiamine deficiency 780 thromboelastography (TEG) 315, toll‐like receptors (TLR) 422
thiazide diuretics 1138–1139 316–317, 317 tooth resorption 14–15
third eyelid 737, 1261–1262, 1262 thromboelastometry (ROTEM) topical decontamination 441
thoracic focused assessment with 316–317, 317 topical therapy
sonography for trauma thrombolysis 320–321 antifungal therapy 1052
(TFAST) 336, 406 thrombophlebitis 356 atopic dermatitis 1408–1409
thoracocentesis through‐the‐needle catheters 355 bacterial pyodermas 1469
acute respiratory failure 389 thymoma 559 common formulations of topical
monitoring pleural pressure 335, thyroid hormones (T3/T4) agents 1397–1399
339, 343 autoimmune polyglandular miscellaneous skin
respiratory pattern‐based approach syndromes 114 diseases 1497, 1503
to dyspnea 291–292 canine hypothyroidism 71–73 principles of therapy of dermatologic
thoracoscopy 339, 339 diabetes mellitus 97 diseases 1397–1399
thoracotomy 325–330 endocrinology 30–31, 30, 33 total body surface area (TBSA)
arrhythmias 326, 329 feline hyperthyroidism 78–79 446, 449
arterial blood gas analysis 328 neuroendocrinology 36 total body water (TBW)
arterial blood pressure 327 thyroid‐stimulating hormone (TSH) 1069–1070, 1070
complications 329–330 autoimmune polyglandular total hip replacement (THR) 1540
continual effusion and pneumothorax syndromes 114 tourniquets 462
326–327, 330, 335, 343 canine hypothyroidism 71–73 toxic diseases
dyspnea 329 endocrinology 29, 32–33 liver 683–684
electrocardiography 327 neuroendocrinology 36, 40, 40 nonspecific reactive hepatitis due to
fluid therapy 328–329 thyrotropin receptor (TSHR) 76 endotoxins 683
hypotension 326 thyrotropin‐releasing hormone vestibular disease 792–794
hypothermia 326, 329 (TRH) 40, 40, 71 see also drug toxicity
hypoxemia and hypoventilation thyroxine see thyroid hormones toxic epidermal necrolysis
325–326 tick‐borne diseases (TEN) 1424
nursing care 329 ehrlichiosis and toxoplasmosis 1003–1005
oxygen supplementation 329 anaplasmosis 903–912 diagnosis 1004–1005, 1004
pain and pain management Lyme borreliosis 941–944 epidemiology 1003
326, 328 neuromuscular junction etiology/pathophysiology 1003
pathophysiology of diseases 807 history and clinical signs 1004
thoracotomy 325–327 parasitic skin diseases 1460 signalment 1003
postoperative protozoal and protozoa‐like treatment and prognosis 1005
management 328–330 infections 1011–1018 t‐PA see tissue plasminogen activator